Commission Regulation (EC) No 954/1999 of 5 May 1999 amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)
Date: 1999-05-05
Institutions: European Commission
Subjects: animal product, food inspection, foodstuff, veterinary drug, waste

L 118/28

EN

Official Journal of the European Communities

6. 5. 1999

COMMISSION REGULATION (EC) No 954/1999

of 5 May 1999

amending Annex III to Council Regulation (EEC) No 2377/90 laying down a
Community procedure for the establishment of maximum residue limits of
veterinary medicinal products in foodstuffs of animal origin

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

maximum residue limits
always be established for muscle or fat tissues;

should therefore also

Having regard to the Treaty establishing the European
Community,

Having regard to Council Regulation (EEC) No 2377/90
of 26 June 1990 laying down a Community procedure for
the establishment of maximum residue limits of veter-
inary medicinal products in foodstuffs of animal origin (1),
as last amended by Commission Regulation (EC) No 953/
1999 (2), and in particular Articles 7 and 8 thereof,

(1) Whereas, in accordance with Regulation (EEC) No
2377/90, maximum residue limits must be estab-
lished progressively for all pharmacologically active
substances which are used within the Community
in veterinary medicinal products
intended for
administration to food-producing animals;

(2) Whereas maximum residue limits should be estab-
lished only after
the examination within the
Committee for Veterinary Medicinal Products of all
the relevant information concerning the safety of
residues of
the
consumer of foodstuffs of animal origin and the
impact of residues on the industrial processing of
foodstuffs;

the substance concerned for

(3) Whereas, in establishing maximum residue limits
for residues of veterinary medicinal products in
foodstuffs of animal origin, it is necessary to specify
the animal species in which residues may be
present, the levels which may be present in each of
the relevant meat tissues obtained from the treated
animal (target tissue) and the nature of the residue
which is relevant for the monitoring of residues
(marker residue);

(4) Whereas, for the control of residues, as provided for
in appropriate Community legislation, maximum
residue limits should usually be established fo the
target tissues of liver or kidney; whereas, however,
the liver and kidney are frequently removed from
and
carcases moving

in international

trade,

(5) Whereas, in the case of veterinary medicinal pro-
ducts intended for use in laying birds,
lactating
animals or honey bees, maximum residue limits
must also be established for eggs, milk or honey;

(6) Whereas, in order to allow for the completion of
scientific studies, cypermethrin, alphacypermethrin
and cefquinome should be inserted into Annex III
to Regulation (EEC) No 2377/90;

(7) Whereas a period of 60 days should be allowed
before the entry into force of this Regulation in
order to allow Member States to make any adjust-
ment which may be necessary to the authorisations
to place
veterinary medicinal products
concerned on the market which have been granted
in
81/
accordance with Council Directive
851/EEC (3), as last amended by Directive 93/
40/EEC (4), to take account of the provisions of this
Regulation;

the

(8) Whereas the measures provided for in this Regula-
tion are in accordance with the opinion of the
Standing Committee on Veterinary Medicinal
Products,

HAS ADOPTED THE FOLLOWING REGULATION:

Article 1

Annex III to Regulation (EEC) No 2377/90 is hereby
amended as set out in the Annex hereto.

Article 2

This Regulation shall enter into force on the 60th day
following its publication in the Official Journal of the
European Communities.

(1) OJ L 224, 18.8.1990, p. 1.
(2) See page 23 of this Official Journal.

(3) OJ L 317, 6.11.1981, p. 1.
(4) OJ L 214, 24.8.1993, p. 31.

6. 5. 1999

EN

Official Journal of the European Communities

L 118/29

This Regulation shall be binding in its entirety and directly applicable in all Member
States.

Done at Brussels, 5 May 1999.

For the Commission

Martin BANGEMANN

Member of the Commission

Annex III to Regulation (EEC) No 2377/90 is amended as follows:

ANNEX

1.

Anti-infectious agents

1.2. Antibiotics

1.2.4. Cephalosporins

Pharmacologically active
substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘Cefquinome

Cefquinome

Porcine

50 lg/kg
50 lg/kg
100 lg/kg
200 lg/kg

Muscle
Skin + fat
Liver
Kidney

Provisional MRLs expire on 1.1.2000'

2.

Antiparasitic agents

2.2. Agents acting against ectoparasites

2.2.3. Pyrethroids

Pharmacologically active
substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

‘Alphacypermethrin

Cypermethrin (sum of
isomers)

Bovine, ovine

Chicken

20 lg/kg
200 lg/kg
20 lg/kg
20 lg/kg
20 lg/kg

Muscle
Fat
Liver
Kidney
Milk

Further provisions in
Council Directive
93/57/EC (OJ L 211,
23.8.1992, p. 1) are to be
observed

50 lg/kg
50 lg/kg
50 lg/kg
50 lg/kg
50 lg/kg

Muscle
Skin + fat
Liver
Kidney
Eggs

Provisional MRLs expire on 1.1.2002

L
1
1
8
/
3
0

E
N

O

f
f
i
c
i
a
l

J
o
u
r
n
a
l

o
f

t
h
e
E
u
r
o
p
e
a
n
C
o
m
m
u
n
i
t
i
e
s

6

.

5

.

1
9
9
9

Pharmacologically active
substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

Cypermethrin

Cypermethrin (sum of
isomers)

Bovine, ovine, caprine

Porcine

Chicken

Salmonidae

Provisional MRLs expire on 1.1.2002'

20 lg/kg
200 lg/kg
20 lg/kg
20 lg/kg
20 lg/kg

Muscle
Fat
Liver
Kidney
Milk

Further provisions in
Council Directive
93/57/EC (OJ L 211,
23.8.1992, p. 1) are to be
observed

Muscle
Skin + fat
Liver
Kidney

Muscle
Skin + fat
Liver
Kidney
Eggs

Muscle and skin in natural
proportions

20 lg/kg
200 lg/kg
20 lg/kg
20 lg/kg

50 lg/kg
50 lg/kg
50 lg/kg
50 lg/kg
50 lg/kg

50 lg/kg

6

.

5

.

1
9
9
9

E
N

O

f
f
i
c
i
a
l

J
o
u
r
n
a
l

o
f

t
h
e
E
u
r
o
p
e
a
n
C
o
m
m
u
n
i
t
i
e
s

L
1
1
8
/
3
1